Jasbir Seehra, founder and chief scientific officer, Acceleron Pharma
Susan Severance, research project manager/research associate, Oregon Health & Science University [Added: 3:10 pm, 10/7/10]
Gray Shaw, co-founder, Aarvon Biosciences
Richard Shea, chief financial officer, Momenta Pharmaceuticals
Todd Shegog, senior vice president of finance and chief financial officer, Millennium: The Takeda Oncology Company
Matt Sherman, chief medical officer, Acceleron Pharma
Charles Shoemaker, professor, Division of Infectious Diseases, Department of Biomedical Sciences, Tufts Cummings School of Veterinary Medicine [Added: 9:45 pm, 3/22/10]
Mary Simchik, senior EH&S specialist II, Pfizer [Added: 2 pm, 4/2/10]
Martin Sinacore, associate director cell culture development, site head, Biogen Idec
Christine Soter, manager, documentation and compliance, Biogen Idec [Added: 7:05 pm, 4/12/10]
Jennifer Smith, senior director, quality, Momenta Pharmaceuticals [Added: 10:30 am, 3/26/10]
Colleen Surrette Sproul, principal, Contracts Associates [Added: 12:10 pm, 10/28/10]
Mark Stahl, director of protein engineering, global biotherapeutics technologies, Pfizer [Added: 8:20 am, 10/27/10]
Lawrence Stein, former general counsel, Wyeth
Bob Steininger, senior vice president of manufacturing, Acceleron Pharma
Neil Steinmeyer, senior research scientist II, analytical research and development, Pfizer [Added: 1 pm, 4/5/10]
Dave Stepp, principal scientist, Genzyme
David Stone, managing director, Liberty Tree Advisors
Jay Stoudemire, senior preclinical development expert
Lauri Sweeney, senior clinical trial manager, Biogen Idec [Added: 2:30 pm, 5/21/10]
Mary Switzer, senior research scientist II, Pfizer [Added: 10:30 am, 3/26/10]
Pam Szklut, principal research scientist II, Pfizer [Added: 1:45 pm, 3/25/10]
Bruce Tangarone, principle research scientist I, analytical research and development, Pfizer [Added: 6:30 pm, 3/31/10]
Scott Thies, senior director of stem cell biology, Fate Therapeutics
Gregg Timony, director of preclinical sciences, Receptos [Added: 9 am, 3/24/10]
Carol Tranfaglia, manager of clinical data development, Cell Therapeutics
Greg Tucker-Kellogg, chief technology officer, and senior director systems biology, Lilly Singapore Centre for Drug Discovery
Katherine Turner, biotechnology professional
Victor Van Cleave, vice president of research and development, Meridien Life Science
James Vath, head of discovery and development, Zafgen
Jennifer Vath, independent pharmaceuticals professional
Trudi Veldman, director of biologics generation, Abbott Bioresearch Center
Jessica Vozella, senior contract and licensing attorney, LCLS [Added: 8:10 pm, 3/2/12]
Chris Wang, senior clinical research scientist, Novartis Vaccines and Diagnostics
Jack Wang, associate director, Adnexus Therapeutics
Nadine Weich, biopharmaceutical R&D professional
Jim Whalen, president, ANOVA Pharma Consultancy [Added: 3:35 pm 5/20/10]
Rick Williams, senior project manager, process transfer and manufacturing, Pfizer. Retiring April 30, 2010 [Added: 12:05 am, 4/2/10]
Mark Williamson, medical science liaison, Millennium: The Takeda Oncology Company
Dwight Winters, senior scientist, Amgen [Added: 11:30 am, 6/1/10]
JoAnn Witek, senior scientist and director, cell biology, Hydra Biosciences [Added: 12:50 pm, 3/23/10]
Roslynn Witte, regional director, hematology, Pfizer Pharmaceuticals [Added: 10:30 am, 3/26/10]
Steve Wolpe, senior vice president of research, Noble Life Sciences [Updated: 1:40 pm, 10/15/11]
Gordon Wong, vice president of new ventures, Biogen Idec
Clive Wood, senior vice president and head, global biologics, Bayer Schering Pharma [Added: 9:45 pm Eastern, 3/22/10]
Becky Woodcock, manager of coagulation products, CSL Behring
Mary Beth Woodin, president at MBK Associates and Menopause Alliance [Added: 9 am, 3/24/10]
Michele (Koethe) Yetman, vice president of human resources for technology, Amazon.com
Scott Young, chief operating officer, Link Medicine [Added: 11:30 am, 11/08/10]
